InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-21.9%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by KLAUSNER ARTHUR J, Director. Insider active across 1 company, notably Monopar Therapeutics. Cumulatively, 14 reports have been logged. Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
2,533 sharesCommon StockSEC:0001437749-24-000484:0
2,533 sharesCommon StockSEC:0001437749-23-027585:0
2,534 sharesCommon StockSEC:0001437749-23-019260:0
2,533 sharesCommon StockSEC:0001437749-23-009336:0
2,859 sharesCommon StockSEC:0001437749-23-000171:0
2,859 sharesCommon StockSEC:0001654954-22-013279:0
2,859 sharesCommon StockSEC:0001654954-22-009151:0
2,859 sharesCommon StockSEC:0001654954-22-004481:0
751 sharesCommon StockSEC:0001654954-22-000114:0
751 sharesCommon StockSEC:0001654954-22-000114
751 sharesCommon StockSEC:0001654954-21-010716:0
751 sharesCommon StockSEC:0001654954-21-010716
752 sharesCommon StockSEC:0001654954-21-007599:0
752 sharesCommon StockSEC:0001654954-21-007599
14 of 14 declarations
About KLAUSNER ARTHUR J
Arthur J. Klausner is a Board Member at Monopar Therapeutics. He is involved in overseeing the company's operations and strategic decision-making. With experience in the biopharmaceutical sector, he contributes to the strategic direction of Monopar, which focuses on developing cancer treatments.
